Langsung ke konten utama

A silly note

You're the one who started reach me again after all the silence

You don't know how I tried to mute any things related to you

I was successfully working on that, although my mind was never failed to remember you

Turns out, the first message you sent after a long-break, was mean nothing

You wanted something from me, you get it, and that's all

Well, I knew, but I just let it happened

I was happy for that short time we spend together, a very short time~

Then I completely lost myself trying to understand what was just happened

I want to erase all memories, to erase you from my life, completely, without any single trace

But again, it would just be a waste of time

The harder I try to forget you, the more I'll remember you

So, tell me, what should I do?

When all I want is you

When all I want to do is reach you out

When all I want to do is to be with you

When all I want to do is seeing you

But you don't want anything about me, at least from what I know so far

I have told you how I feel about you, I dared myself to confess that I like you

And I knew exactly what your answer would be at that time, I was and wasn't prepared at the same time

It's so pathetic that I manifest you on my mind, a small and fragile place

What I want?

I want to be happy, with or without you

It's just a silly note, after many times of hurtful feelings I earn by thinking about you.

I wish nothing, but the best, for me, of course.

Komentar

Postingan populer dari blog ini

How to Conduct a Clinical Trial with Good Clinical Practice

Clinical trials are essential for developing new treatments and improving health outcomes for patients. However, conducting a clinical trial is not a simple task. It requires careful planning, execution, and reporting to ensure the quality and validity of the data and the safety and well-being of the participants. This is where Good Clinical Practice (GCP) comes in. GCP is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects 1 . GCP aims to provide a unified standard for the ICH regions (the European Union, Japan, the United States, Canada, Switzerland, Brazil, Australia and South Korea) to facilitate the mutual acceptance of clinical data by the regulatory authorities in these jurisdictions 2 . GCP is based on the principles of respect for human dignity, protection of human rights, and assurance of the welfare of the participants 2 . GCP also ensures that the data generated f

Surat titik-titik #2

Halo pembaca setia Topeng Malam's Blog, terimakasih atas kunjungan dan waktu nya untuk membaca postingan-postingan ku yang gag jelas hahaha... Jangan bosen-bosen komentar di blog ku, dan jangan sungkan-sungkan ngasih saran bahkan kritikan di setiap postingan. aku bakalan seneng kalo kalian bisa bantu aku bikin blog ini makin berkembang lagi. Thankyou Jadi ini ada surat, lanjutan dari surat yang pertama kemarin, yaitu surat titik-titik #1 . yang belum baca silahkan dibaca dulu. Nah surat kedua ini aku buat satu hari setelah surat pertama, yaitu tanggal 9/3/2016. Karena tepat setelah aku membuat surat pertama itu, aku menemukan banyak hal dan semua hal-hal yang ada di surat pertama itu nampak terbuka dan terjawab semua.. Soooo, silahkan dibaca bro sis... Hai B*****, B******* *e**** Masih kuingat betul tanggal 8/3/2016 kemarin aku menuliskan sebuah surat untukmu. Ya, sebuah surat yang kamu tidak akan pernah membacanya mungkin. Karena aku tidak berencana sama sekali untuk me